Payne Stephen, Wick Scott, Carr Peter A, Guido Nicholas J
MIT Lincoln Laboratory, Lexington, Massachusetts, USA.
Appl Biosaf. 2024 Jun 20;29(2):108-119. doi: 10.1089/apb.2023.0025. eCollection 2024 Jun.
Organisms engineered with synthetic genes and genomes have the potential to play critical roles to address important issues in the environment, human health, and manufacturing. Engineered genetic biocontainment technologies are needed to manage the risks of unintended consequences when deploying these biological systems in consultation with the biosafety and biosecurity communities. Metrics measuring genetic biocontainment and a methodology to apply them are required to determine which genetic biocontainment technologies warrant further development for real-world applications. In this study, we develop and apply a systems analysis of the current technical landscape using expert opinion and a metric-based scoring system resulting in a semiquantitative comparative assessment of genetic biocontainment technologies in microorganisms.
Genetic biocontainment technologies were evaluated according to multiple metrics, falling into two broad classes: feasibility and applicability. Specific genetic biocontainment example scenarios and generalized categories were scored with these metrics. Gap analysis was carried out, indicating particular areas where genetic biocontainment can be improved.
Metric analysis scoring of feasibility and applicability enabled prioritization of genetic biocontainment technologies for real-world applications. Gap analysis showed that technology readiness and containment stability scored low for a number of scenarios and categories, indicating a general need for further development before they can be ready for deployment.
Developing an assessment framework with defined metrics produced a straightforward system for evaluating genetic biocontainment strategies intended for various real-world applications. Use of the methodology also provided insights into existing gaps in genetic biocontainment strategies, and by altering the metrics, can be applied to other biotechnologies.
利用合成基因和基因组构建的生物体有潜力在解决环境、人类健康和制造业等重要问题方面发挥关键作用。在与生物安全和生物安保领域进行协商后,需要采用工程化基因生物遏制技术来管理在部署这些生物系统时产生意外后果的风险。需要衡量基因生物遏制的指标及其应用方法,以确定哪些基因生物遏制技术值得进一步开发用于实际应用。在本研究中,我们利用专家意见和基于指标的评分系统,对当前技术格局进行系统分析,从而对微生物中的基因生物遏制技术进行半定量比较评估。
根据多个指标对基因生物遏制技术进行评估,这些指标分为两大类:可行性和适用性。利用这些指标对特定的基因生物遏制示例场景和通用类别进行评分。进行了差距分析,指出了基因生物遏制可改进的特定领域。
可行性和适用性的指标分析评分能够对用于实际应用的基因生物遏制技术进行优先级排序。差距分析表明,在许多场景和类别中,技术成熟度和遏制稳定性得分较低,这表明在它们能够准备好部署之前,普遍需要进一步开发。
开发一个具有明确指标的评估框架,产生了一个用于评估针对各种实际应用的基因生物遏制策略的简单系统。该方法的使用还提供了对基因生物遏制策略中现有差距的见解,并且通过改变指标,可应用于其他生物技术。